会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD OF MANUFACTURING COATING AGENT FOR DRUG RELEASING STENT AND COATING AGENT FOR DRUG RELEASING STENT MANUFACTURED THEREBY
    • 制造用于药物释放的涂层剂的方法和用于药物释放的涂层剂
    • US20120316127A1
    • 2012-12-13
    • US13491145
    • 2012-06-07
    • Kyong-Min SHINKun Na
    • Kyong-Min SHINKun Na
    • A61K31/7068A61P35/00B05D5/00
    • A61L31/16A61L31/10A61L2300/416A61L2300/608A61L2420/02C08L75/04C08L27/18
    • This invention relates to a method of manufacturing a coating agent for a drug releasing stent and to a coating agent for a drug releasing stent manufactured thereby. This method includes (1) dissolving polyurethane in tetrahydrofuran, (2) dissolving pluronic F-127 in tetrahydrofuran, (3) dissolving a gemcitabine compound in ethanol, (4) mixing these three solutions obtained in (1) to (3) thus preparing a solution mixture, (5) applying the solution mixture obtained in (4) on a stent coated with a Teflon film, (6) drying the stent of (5) for a predetermined period of time and then immersing the stent in a polyurethane solution in tetrahydrofuran, and (7) removing the stent immersed in (6) from the polyurethane solution and then drying the stent, so that the rate of release of an anti-cancer drug applied on the stent can be continuously and maximally improved thereby maximizing anti-cancer efficacy.
    • 本发明涉及一种制造药物释放支架用涂布剂的方法及其制造的药物释放支架用涂布剂。 该方法包括(1)将聚氨酯溶于四氢呋喃中,(2)将普鲁尼克F-127溶解在四氢呋喃中,(3)将吉西他滨化合物溶于乙醇中,(4)将(1)至(3)中得到的三种溶液混合, 溶液混合物,(5)将(4)中得到的溶液混合物涂布在涂有特氟龙膜的支架上,(6)将(5)的支架干燥规定时间,然后将支架浸渍在聚氨酯溶液 在四氢呋喃中,和(7)从聚氨酯溶液中取出浸没在(6)中的支架,然后干燥支架,使得施加在支架上的抗癌药物的释放速率可以连续和最大程度地提高,从而最大化抗 - 功效
    • 9. 发明授权
    • pH-sensitive polymeric micelles for drug delivery
    • 用于药物递送的pH敏感聚合物胶束
    • US07229973B2
    • 2007-06-12
    • US10640739
    • 2003-05-19
    • You Han BaeKun NaEun Seung Lee
    • You Han BaeKun NaEun Seung Lee
    • A61K31/704
    • C07D233/64A61K9/0019A61K9/1075C07D413/06C08F8/30
    • Mixed micelles containing poly(L-histidine)-poly(ethylene glycol) block copolymer and poly(L-lactic acid)-poly(ethylene glycol) block copolymer are a pH-sensitive drug carrier that release the drug in an acidic microenvironment, but not in the blood. Since the microenvironment of solid tumors is acidic, these mixed micelles are useful for treating cancer, including those cancers exhibiting multidrug resistance. Targeting ligands, such as folate, can also be attached to the mixed micelles for enhancing drug delivery into cells. Methods of making poly(L-histidine), synthetic intermediates, and block copolymers are also described.
    • 含有聚(L-组氨酸) - 聚(乙二醇)嵌段共聚物和聚(L-乳酸) - 聚(乙二醇)嵌段共聚物的混合胶束是在酸性微环境中释放药物的pH敏感药物载体,但是 不在血中 由于实体瘤的微环境是酸性的,所以这些混合胶束可用于治疗癌症,包括那些显示出多药耐药性的癌症。 靶向配体如叶酸也可以连接到混合的胶束上,以增强药物递送到细胞中。 还描述了制备聚(L-组氨酸),合成中间体和嵌段共聚物的方法。